Global Hunter Syndrome Treatment Market Report and Forecast 2024-2032

Global Hunter Syndrome Treatment Market Outlook

The global hunter syndrome treatment market attained a value of nearly USD 1045.22 million in 2023. The market is estimated to grow in the forecast period of 2024-2032 at a CAGR of 6.30% to reach about USD 1811.41 million by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America Holds a Considerable Share of the Market for Hunter Syndrome Treatment

The increasing awareness about rare diseases, surging healthcare expenditure, and strict regulations for orphan drug development are driving the growth of the hunter syndrome treatment market in North America. The United States holds a significant share in the market for hunter syndrome treatment in North America owing to recent advancements in medical sciences and the increasing coverings of government-sponsored health insurance. Meanwhile, the market for hunter syndrome treatment in the Asia Pacific region is likely to grow due to the robust growth of the healthcare industry in emerging economies like China and India. Moreover, the surging investments in advanced research and development (R&D) activities for novel treatment products of hunter syndrome in countries like India is expected to propel the market growth of hunter syndrome treatment during the forecast period.

Market Segmentation

Hunter syndrome is a unique, inherited disorder in which the body does not appropriately digest (break down) sugar molecules in the body. Treatment for hunter syndrome aids in the management of potential problems associated with the condition. The objective of treatment is to slow the progression of the disease and improve the quality of life. Enzyme replacement therapy is considered as one of the most effective treatments of hunter syndrome.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The market for hunter syndrome treatment, by treatment type, is divided into:

• Enzyme Replacement Therapy (ERT)
  • Elaprase + Tak-609
  • Hunterase 
  • Izcargo 
• Haematopoietic Stem Cell Transplant (HSCT)
  • Umbilical Cord Transplant
  • Bone Marrow Transplant
• Others

The market can be broadly categorised on the basis of complications into:

• Respiratory Disorders
• Neurological Disorders
• Cardiovascular
• Musculoskeletal
• Gastrointestinal Disorders
• Ophthalmic
• Audiologic
• Dental
• Others

Based on route of administration, the market is bifurcated into:

• Intravenous
• Intracerebroventricular (ICV)/ Intrathecal

By end use, the market is segmented into:

• Hospitals
• Speciality Clinics
• Others

Based on the distribution channel, the market is classified into:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

The EMR report looks into the regional markets of hunter syndrome treatment like Latin America, North America, Europe, the Asia Pacific, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Emergence of Novel Therapies Likely to Bolster the Market Growth of Hunter Syndrome Treatment

The increasing awareness regarding hunter syndrome and its treatment options, along with the growing healthcare infrastructure and the emergence of novel hunter syndrome therapies, is expected to drive the growth of the market during the forecast period. The increasing accessibility of therapeutic options and surging investments by various governments in the healthcare industry like sponsored health insurance are likely to propel the hunter syndrome treatment market growth. Technological advancements and innovations are also likely to provide lucrative opportunities to the market growth of hunter syndrome treatment.
 
Moreover, based on treatment type, enzyme replacement therapy (ERT) segment is projected to gain momentum over the forecast period in the market for hunter syndrome treatment across the globe as ERT has fewer side effects than other treatments and consists of longer drug history as well as wider availability.

Key Players in the Global Market for Hunter Syndrome Treatment

The report presents a detailed analysis of the following key players in the global hunter syndrome treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Denali Therapeutics Inc.
• ArmaGen, Inc.
• Sangamo Therapeutics Inc.
• CANbridge Life Sciences Ltd.
• REGENXBIO Inc.
• Others

The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report